Journal ArticleOPEN ACCESS

High On‐Aspirin Platelet Reactivity and Clinical Outcome in Patients With Stable Coronary Artery Disease: Results From ASCET (Aspirin Nonresponsiveness and Clopidogrel Endpoint Trial)

  • Pettersen A
  • Seljeflot I
  • Abdelnoor M
  • et al.
Journal of the American Heart Association (2012) 1(3)
DOI: 10.1161/jaha.112.000703
N/ACitations
Citations of this article
72Readers
Mendeley users who have this article in their library.

Abstract

Patients with stable coronary artery disease on single-antiplatelet therapy with aspirin are still at risk for atherothrombotic events, and high on-aspirin residual platelet reactivity (RPR) has been suggested as a risk factor.

Cite

CITATION STYLE

APA

Pettersen, A. R., Seljeflot, I., Abdelnoor, M., & Arnesen, H. (2012). High On‐Aspirin Platelet Reactivity and Clinical Outcome in Patients With Stable Coronary Artery Disease: Results From ASCET (Aspirin Nonresponsiveness and Clopidogrel Endpoint Trial). Journal of the American Heart Association, 1(3). https://doi.org/10.1161/jaha.112.000703

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free